| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Brooklyn ImmunoTherapeutics, Inc. | Chief Medical Officer | Restricted Stock Units | 60.5K | $150K | $2.48 | 20 Sep 2022 | Direct |
| Brooklyn ImmunoTherapeutics, Inc. | Chief Medical Officer | Common Stock | 20.2K | $50K | $2.48 | 20 Sep 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CRDF | Cardiff Oncology, Inc. | 16 Jun 2025 | 0 | $0 | 3 | Chief Medical Officer | 08 Jul 2025, 16:05 |
| ERNA | Brooklyn ImmunoTherapeutics, Inc. | 20 Sep 2022 | 2 | $0 | 4 | Chief Medical Officer | 21 Sep 2022, 19:00 |
| ERNA | Brooklyn ImmunoTherapeutics, Inc. | 11 Mar 2022 | 1 | $0 | 4/A | Chief Medical Officer | 17 Mar 2022, 21:00 |
| ERNA | Brooklyn ImmunoTherapeutics, Inc. | 20 Sep 2021 | 2 | $0 | 4 | Chief Medical Officer | 22 Sep 2021, 16:57 |
| ERNA | Brooklyn ImmunoTherapeutics, Inc. | 20 Sep 2021 | 0 | $0 | 3 | Chief Medical Officer. Exhibit List: Exhibit 24 - Power of Attorney | 22 Sep 2021, 16:50 |